Literature DB >> 28882968

Rectosigmoidian Involvement in Advanced-stage Ovarian Cancer - Intraoperative Decisions.

Nicolae Bacalbasa1, Irina Balescu2, Simona Dima3.   

Abstract

BACKGROUND/AIM: Ovarian cancer remains one of the most commonly encountered malignancies affecting women worldwide, that is unfortunately commonly diagnosed in advanced stages of the disease. In these stages, the tumoral process usually involves the surrounding viscera throughout contiguity or induces the apparition of distant metastases via peritoneal, lymphatic or hematogenous spread, multiple resections being needed in order to achieve a good control of the disease. PATIENTS AND METHODS: In the present study, we present a case series of 12 patients in whom various surgical procedures on the rectosigmoidian loop were performed in order to achieve debulking surgery to no residual disease.
RESULTS: Digestive tract resections consisted of rectosigmoidian resection with left colostomy in three cases, low rectosigmoidian resections with anastomosis in eight cases and a stripping procedure of the peritoneal layer in one case.
CONCLUSION: Due to the close proximity of the digestive and gynecological tract, advanced-stage ovarian tumors frequently involve the rectosigmoidian loop, imposing association of digestive tract surgical procedures. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Advanced stage ovarian cancer; peritonectomy; rectosigmoidian loop; resection

Mesh:

Year:  2017        PMID: 28882968      PMCID: PMC5656875          DOI: 10.21873/invivo.11156

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  23 in total

1.  Modified posterior exenteration for ovarian cancer.

Authors:  S M Eisenkop; R H Nalick; N N Teng
Journal:  Obstet Gynecol       Date:  1991-11       Impact factor: 7.661

2.  Comparison of the efficacy of low anterior resection with primary anastomosis and Hartmann's procedure in advanced primary or recurrent epithelial ovarian cancer.

Authors:  Hee Seung Kim; Eun Na Kim; Seung-Yong Jeong; Hyun Hoon Chung; Yong Beom Kim; Jae Weon Kim; Kyu Joo Park; Noh Hyun Park; Yong Sang Song; Jae-Gahb Park; Soon-Beom Kang
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2011-02-02       Impact factor: 2.435

3.  Douglas peritonectomy compared to recto-sigmoid resection in optimally cytoreduced advanced ovarian cancer patients: analysis of morbidity and oncological outcome.

Authors:  V Gallotta; F Fanfani; G Vizzielli; G Panico; C Rossitto; M L Gagliardi; P A Margariti; M G Salerno; G F Zannoni; F Pacelli; G Scambia; A Fagotti
Journal:  Eur J Surg Oncol       Date:  2011-09-25       Impact factor: 4.424

4.  Results of Primary Cytoreductive Surgery in Advanced-stage Epithelial Ovarian Cancer: A Single-center Experience.

Authors:  Nicolae Bacalbasa; Simona Dima; Irina Balescu; Leonard David; Vladislav Brasoveanu; Irinel Popescu
Journal:  Anticancer Res       Date:  2015-07       Impact factor: 2.480

5.  Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study.

Authors:  Roberta De Angelis; Milena Sant; Michel P Coleman; Silvia Francisci; Paolo Baili; Daniela Pierannunzio; Annalisa Trama; Otto Visser; Hermann Brenner; Eva Ardanaz; Magdalena Bielska-Lasota; Gerda Engholm; Alice Nennecke; Sabine Siesling; Franco Berrino; Riccardo Capocaccia
Journal:  Lancet Oncol       Date:  2013-12-05       Impact factor: 41.316

6.  Role of rectosigmoidectomy and stripping of pelvic peritoneum in outcomes of patients with advanced ovarian cancer.

Authors:  Giovanni D Aletti; Karl C Podratz; Monica B Jones; William A Cliby
Journal:  J Am Coll Surg       Date:  2006-08-23       Impact factor: 6.113

7.  Bowel resection at the time of primary cytoreduction for epithelial ovarian cancer.

Authors:  N Gillette-Cloven; R A Burger; B J Monk; D S McMeekin; S Vasilev; P J DiSaia; M F Kohler
Journal:  J Am Coll Surg       Date:  2001-12       Impact factor: 6.113

8.  Survival impact of multiple bowel resections in patients undergoing primary cytoreductive surgery for advanced ovarian cancer: a case-control study.

Authors:  Ritu Salani; Marianna L Zahurak; Antonio Santillan; Robert L Giuntoli; Robert E Bristow
Journal:  Gynecol Oncol       Date:  2007-09-12       Impact factor: 5.482

9.  Hematogenous Splenic Metastases as an Independent Negative Prognosis Factor at the Moment of Primary Cytoreduction in Advanced Stage Epithelial Ovarian Cancer--A Single Center Experience.

Authors:  Nicolae Bacalbasa; Irina Balescu; Simona Dima; Vladislav Brasoveanu; Irinel Popescu
Journal:  Anticancer Res       Date:  2015-10       Impact factor: 2.480

10.  Multiple large bowel resections: potential risk factor for anastomotic leak.

Authors:  Eleftheria Kalogera; Sean C Dowdy; Andrea Mariani; Amy L Weaver; Giovanni Aletti; Jamie N Bakkum-Gamez; William A Cliby
Journal:  Gynecol Oncol       Date:  2013-04-08       Impact factor: 5.482

View more
  4 in total

1.  The Influence of "Omental Cake" Presence on the Completeness of Cytoreduction in Advanced-stage Ovarian Cancer.

Authors:  Nicolae Bacalbasa; Camelia Diaconu; Laura Iliescu; Cornel Savu; Ovidiu Gabriel Bratu; Ciprian Bolca; Dragos Cretoiu; Alexandru Filipescu; Simona Dima; Cristian Balalau; Irina Balescu
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

2.  Subtotal Colectomy as Part of Debulking Surgery for Advanced-stage Ovarian Cancer.

Authors:  Nicolae Bacalbasa; Camelia Diaconu; Laura Iliescu; Simona Dima; Ovidiu Gabriel Bratu; Dragos Cretoiu; Adrian Neacsu; Alexandru Filipescu; Cornel Savu; Irina Balescu
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

3.  Association Between Secondary Peritoneal Hydatidosis and Peritoneal Carcinomatosis from Ovarian Cancer - A Case Report.

Authors:  Nicolae Bacalbasa; Irina Balescu; Iulian Brezean; Mihaela Vilcu; Vladislav Brasoveanu
Journal:  In Vivo       Date:  2018 Jul-Aug       Impact factor: 2.155

4.  A Specific Survival Score for Patients Receiving Local Therapy for Single Brain Metastasis from a Gynecological Malignancy.

Authors:  Dirk Rades; Liesa Dziggel; Steven E Schild
Journal:  In Vivo       Date:  2018 Jul-Aug       Impact factor: 2.155

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.